Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria - Wikidata - wikimedia - TriplyDB

Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria

Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria

http://www.wikidata.org/entity/Q24563321

about

Protein substitute for children and adults with phenylketonuria Nutritional Management of Phenylketonuria Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids Phenylketonuria: a review of current and future treatments Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations Phenylketonuria: translating research into novel therapies Large Neutral Amino Acid Supplementation Exerts Its Effect through Three Synergistic Mechanisms: Proof of Principle in Phenylketonuria Mice Non-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 mice In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.Tyrosinemia type III in an asymptomatic girl Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.Pharmacologic inhibition of L-tyrosine degradation ameliorates cerebral dopamine deficiency in murine phenylketonuria (PKU)Amino acid supplementation affects imprinted gene transcription patterns in parthenogenetic porcine blastocysts.Novel pharmacological chaperones that correct phenylketonuria in mice.Large neutral amino acids in the treatment of PKU: from theory to practice.Phenylalanine hydroxylase deficiency.A comparative analysis of biclustering algorithms for gene expression data.Phenylalanine sensitive K562-D cells for the analysis of the biochemical impact of excess amino acid.Phenylketonuria: an inborn error of phenylalanine metabolism.Mechanisms of disease: the blood-brain barrier.Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics.A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuria.The Amino Acid Specificity for Activation of Phenylalanine Hydroxylase Matches the Specificity for Stabilization of Regulatory Domain Dimers.Phenylketonuria: nutritional advances and challenges An examination of the blood-brain barrier in health and disease.Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats.Purification and use of glycomacropeptide for nutritional management of phenylketonuria.Nutritional management of PKU with glycomacropeptide from cheese whey.Classical maple syrup urine disease and brain development: principles of management and formula design Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders.Progress toward cell-directed therapy for phenylketonuria.Requirements for a minimum standard of care for phenylketonuria: the patients' perspective.Undiagnosed maternal phenylketonuria: own clinical experience and literature review.Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria.Clinical therapeutics for phenylketonuria.Conversion of a laboratory-based test for phenylalanine detection to a simple paper-based format and implications for PKU screening in low-resource settings.Protein substitutes for phenylketonuria in Europe: access and nutritional composition.Individual blood-brain barrier phenylalanine transport determines clinical outcome in phenylketonuria.Leucine suppresses acid-induced protein wasting in L6 rat muscle cells.Improved Measurement of Brain Phenylalanine and Tyrosine Related to Neuropsychological Functioning in Phenylketonuria.

P2860

Q24245498-3F411C94-0630-420B-9A21-1EDB0DB49EB0 Q24613843-C2C622A9-9203-4D24-A2D5-8B222B2EAD15 Q24645084-ACCAAF95-F4AD-4866-A823-D774A7E907A3 Q26770291-47BB3BB6-42D6-44B9-8033-FF3C9A0D0FE4 Q26783331-27A4919B-9E5B-4C07-87E5-153F08436895 Q27015749-2FEFC874-1E56-4237-A739-70A3C5C7E783 Q28551217-4396815D-057E-4176-9C1B-4942ABFB618A Q28703649-67F6AB15-C10E-4764-AAFE-781E22A18714 Q31028468-C56C90C1-DD31-4D90-B1D6-F9BE6B5E14DA Q33800094-431EAFED-22BB-4511-8C8E-ABB25DB0ACBE Q33829216-23635E79-226A-493F-A432-7B58D6408DD5 Q33993821-9C5B3ABE-7E90-4258-91D3-6DF84B8E05AB Q34122707-992CFFF3-7268-462D-A1D2-1722BD575C7F Q34127906-4F07C857-3B73-4B92-AFFC-11176BF7F785 Q34145811-62D2CD04-947F-47A5-87BC-8A555C3DD433 Q34183829-970BA94D-494D-46A9-A2DB-66EE5F3E2C39 Q34330462-6B8D2AAB-7CD0-41B8-8208-3C23D9D99B61 Q34460539-6A4AC174-9739-4C7C-9454-6DCCD51F005E Q34787712-28901D1D-465D-4F27-8907-A24F04D9F21E Q35610735-15707FBB-1D25-4F72-AF80-A4A6BEBC45C3 Q35752457-C76461FA-E342-47F8-A18C-56DD8C975300 Q35789606-E376A8B9-61A6-448A-802B-A8FA221F0E70 Q35999931-34B4F888-72FE-4215-B9C4-898573DC88A7 Q36092265-E856C308-D990-454A-AC3D-27ADA250AFE3 Q36143960-A3B7273D-CC1E-40DF-BE52-AB860F2E3D2F Q36522138-E101C2AA-DA08-4A22-B691-56DA49557D6C Q36783467-D6671F79-A6E7-471A-A0A4-BB92A968B347 Q36786748-DE66DE00-9838-4C51-B476-BAA2DD0F0387 Q36900927-D7155E58-B17B-45AD-9C5A-ECEC3BEB2D73 Q37127238-D399875A-8595-4B3D-BBCE-0DC62FC622BA Q37170974-A46FCA13-D174-4DB8-9C74-88398E7764E1 Q37426648-79840081-C775-4716-AA85-680B136E6065 Q37532201-BB38324F-49FC-41EB-9218-BFD1719D7D31 Q38096351-F6F187B3-F385-4817-9258-3E76C6D948EA Q38383086-84F1CEF8-9E42-4BA0-8FBD-28AD75D79A32 Q38393802-03466224-A0B1-4D6B-8036-9FE92B9EFCC7 Q39819235-CDC98DA7-03E7-4268-994C-0AFEDE90D019 Q40681678-5E83A5E8-FD3D-4A6D-85B5-BAE144B38CE1 Q40796874-4AD7BDB8-5D6E-4286-91EA-B4BF465D2099 Q41009118-F7DBDCEB-ECE8-47ED-A5D6-DC07B2FB013D

P2860

Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria

http://www.wikidata.org/entity/Q24563321

description

1999 nî lūn-bûn

@nan

1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Large neutral amino acids bloc ...... patients with phenylketonuria

@ast

Large neutral amino acids bloc ...... patients with phenylketonuria

@en

Large neutral amino acids bloc ...... patients with phenylketonuria

@nl

type

label

Large neutral amino acids bloc ...... patients with phenylketonuria

@ast

Large neutral amino acids bloc ...... patients with phenylketonuria

@en

Large neutral amino acids bloc ...... patients with phenylketonuria

@nl

prefLabel

Large neutral amino acids bloc ...... patients with phenylketonuria

@ast

Large neutral amino acids bloc ...... patients with phenylketonuria

@en

Large neutral amino acids bloc ...... patients with phenylketonuria

@nl

P1433

Q24563321-E3D2417D-6906-4470-A0C4-26C6DA4E4316

P1476

Q24563321-C8A5895B-7DCB-43C1-8ADE-B324888423A3

P2093

Q24563321-22D6112F-6D8F-4B99-9026-14790383852D

Q24563321-41A15115-3419-483A-BC85-1A1025EAC8E2

Q24563321-91AE04B7-6EC7-4512-8E1C-D7486606F3C8

Q24563321-9737B248-0F25-41AD-A63A-00DCD4F5323F

Q24563321-B550E2D7-8B43-43A4-8EEA-9FD1AA995B9D

Q24563321-C4494DB8-C11D-47B3-B0C9-85AF10E3BD46

Q24563321-C93CAD64-D4A7-4615-83AF-5615E4F01A23

P2860

Q24563321-0583B009-F976-4648-8F1B-39F60A1A8E33

Q24563321-133D972B-DC1A-4B72-9605-E97A646D1690

Q24563321-17FF9FF0-20E0-4F9D-A1F8-6230F5D2A459

Q24563321-1A67D05B-7F5F-4600-8F29-69DDE78B5D06

Q24563321-235268A3-59BE-40ED-AF0A-3E42AB958599

Q24563321-2B588801-7730-4770-BB10-9433FA0F0113

Q24563321-2F829781-85C6-4973-B4A3-821114D1739E

Q24563321-466122FD-CD49-4C8B-8946-54092FDC8B13

Q24563321-4C76F70D-5EA3-4849-8F27-478A516722AA

Q24563321-52EE935B-A62A-40FD-92A2-23942DC240E9

P304

Q24563321-9FCF155C-3DE5-421B-9DF4-465899181B80

P31

Q24563321-68A3E505-FCB1-4835-95D7-82C15FD1B9BD

P356

Q24563321-EFA11CA2-0070-4F51-9E2F-5C3B54EC253E

P407

Q24563321-035AA715-A02B-4D7A-B7F8-9F71E4085DC0

P433

Q24563321-2199C806-C994-4EE4-ACE6-86B26A778F73

P478

Q24563321-463D049E-AB79-4166-9C0A-074FE9875E3F

P577

Q24563321-71B1FA9E-41ED-4ADF-BC16-2D08B8063C76

P698

Q24563321-331A5118-E52C-4F56-8361-626B81E3F7F3

P921

Q24563321-18F146F3-E08B-41FD-B2ED-6E00E2C6E440

Q24563321-9B2FE824-EC35-46F3-81FC-059F460C7FA8

Q24563321-ED1E559C-514D-483F-AB23-E900EC7EF349

P932

Q24563321-9F89AEFD-D32E-4F57-B225-B130E7795515

P356

P1433

Journal of Clinical Investigation

P1476

Large neutral amino acids bloc ...... patients with phenylketonuria

@en

P2093

A Rupp

http://www.w3.org/2001/XMLSchema#string

C Boesch

http://www.w3.org/2001/XMLSchema#string

D Rating

http://www.w3.org/2001/XMLSchema#string

E Mayatepek

http://www.w3.org/2001/XMLSchema#string

H J Bremer

http://www.w3.org/2001/XMLSchema#string

J Pietz

http://www.w3.org/2001/XMLSchema#string

R Kreis

http://www.w3.org/2001/XMLSchema#string

P2860

Kinetic analysis of blood-brain barrier transport of amino acids.

A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype.

Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man

The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia.

Abnormal amino acid metabolism and brain protein synthesis during neural development.

Neuropsychology of early-treated phenylketonuria: specific executive function deficits.

Valine, isoleucine, and leucine. A new treatment for phenylketonuria.

Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids.

The effects of chronic hyperphenylalaninaemia on mouse brain protein synthesis can be prevented by other amino acids.

Asymmetrical transport of amino acids across the blood-brain barrier in humans.

P304

1169-78

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI5017

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

1999-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10207169

http://www.w3.org/2001/XMLSchema#string

P921

phenylketonuria

P932

408272

http://www.w3.org/2001/XMLSchema#string